See from worldwide, chemical API mainly spread on five production area : Western Europe, North America, Japan, China and India.
Western Europe(Switzerland, England, Italy, Spain, Belgium, Sweden, Finland, etc)are the main export area of API,it can be regarded as the biggest production area of global APIs, it accounts for 50 % of global output and more than 80% of total output.
North America (including USA ,Canada and Mexico) are the main importing area of API.This areas it consumes about $4 billion of various APIs, accounting for one-third of the world’s API market. For environmental reasons, they are not allowed to produce those API which with environment polluted. Their API consumption rely on 50% importing. and the other half on self production,anyway,the total production just accounts 18% of global quantity.
Japan’s API market size is followed the UAS and bigger than western Europe, except small varieties, they produce most locally, Japanese API is basically “self-sufficient”, year demand is Us $1.5 billion. But as human costs rise and environmental problems become acute, Japan will shift to a net importer of APIs.
India’s situation is similar as China, but its production ability and exporting quantity are lower than China, and it becomes China’s biggest competitor in the international market.
If you are sourcing from Chinese market, there are four advantage varieties you can focus on:
1.Antibiotic-the production standard is approved on international advanced level,and it accounts the 30% of international market shares.
2.Analgesic-antipyretic- Paracetamol, aspirin and analgesin are among the world’s top traditional active pharmaceutical varieties. Paracetamol accounts for nearly 50% of the world’s total output.
3.Vitamins– main representatives as VC and VE, VC produces nearly 50,000 tons and is the world’s largest producer and exporter. VE production has also grown rapidly, reaching more than 12,000 tons. In other vitamins, except for a few varieties, most of the output and export of the world leading.
4.Corticoid- In recent years, due to major technological breakthroughs, cost reduction, quality reached world advanced level, leading market share.
At last,China is also a great original resource of nootropics.